NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 149 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,656 | +6787.6% | 1,520,578 | +6552.0% | 0.00% | – |
| Q2 2023 | $13,149 | -99.5% | 22,859 | -94.8% | 0.00% | -100.0% |
| Q1 2022 | $2,392,000 | -61.7% | 443,800 | -4.0% | 0.01% | -64.0% |
| Q4 2021 | $6,246,000 | -34.0% | 462,300 | -12.3% | 0.02% | -40.5% |
| Q3 2021 | $9,467,000 | +3281.1% | 527,100 | +3262.0% | 0.04% | +2000.0% |
| Q1 2020 | $280,000 | -81.5% | 15,678 | -81.1% | 0.00% | -77.8% |
| Q3 2019 | $1,512,000 | -35.6% | 83,000 | +275.6% | 0.01% | -10.0% |
| Q1 2018 | $2,348,000 | +1748.8% | 22,100 | +140.2% | 0.01% | +900.0% |
| Q1 2016 | $127,000 | -56.9% | 9,200 | -47.4% | 0.00% | -50.0% |
| Q4 2015 | $295,000 | -80.4% | 17,500 | -87.3% | 0.00% | -83.3% |
| Q3 2015 | $1,507,000 | – | 137,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |